Find Resources

This article discusses the Foundation for Opioid Response Efforts (FORE) distribution of $1.3 million in grants to organizations studying the potential permanent adoption of COVID-19 care access measures to promote health equity in opioid use disorder treatment. The grants aim to investigate the impact of temporary policies, such as virtual care, on access to care and patient outcomes. The studies will explore how relaxed prescribing policies for buprenorphine, telehealth strategies, and other COVID-19 measures have affected patient access and outcomes, particularly among underserved populations. The research will inform evidence-based policies to sustain access to better care beyond the pandemic and address the ongoing opioid crisis.

Article outlines how an opioid treatment program in the Bronx, NY adjusted their clinical practice with COVID-19 and their recommendations for treatment programs going forward. Balancing Covid-19 safety and the need to safely administer medications for opioid use disorder, this program ultimately made changes that allowed for more patient-driven treatment plans that enable fewer in person clinic visits. The article advocates for patient-centered care that encourages people to safely self-manage medication, focusing on patient-centered measures in clinical decision-making, and making appropriate changes to payment/insurance models that allow for such patient-centered care.

This article conducts a retrospective case-control study of electronic health records of individuals who were diagnosed with COVID-19 and have a recent diagnosis of substance use disorder (SUD). The results show that those diagnosed with SUD, particularly African Americans and those with opioid use disorder (OUD), are more likely to contract COVID-19, as well as suffer worsening outcomes such as hospitalization and mortality due to COVID-19. This article shows that an increase in SUD screening could be a factor in mitigating the spread of COVID-19 in this community.

This case study discusses how Hawaii’s Behavioral Health Administration (BHA) partnered with state housing services to organize isolation and quarantine services for people experiencing homelessness. This department also focused on substance use disorder and mental illness, so they worked to build partnerships with treatment centers that individuals could enter after quarantine. The BHA has also focused on braiding funding sources between substance use disorder and homelessness efforts to provide more wraparound services and combat the siloization of different departments.

This study describes harm reduction and health services provided by the U.S. syringe services programs (SSPs) in 2019 and changes in provision of those services in 2020. Many SSPs that offered health services in 2019 and remained operational in 2020 increased telehealth provision of mental health and primary care services, increased MOUD provision, and expanded harm reduction services, but most SSPs reduced or stopped on-site HIV and HCV testing. With the record high opioid overdose fatality rates in 2020, sustaining the trajectory of SSP growth and innovation leading up to and through 2020 requires ensuring adequate and flexible funding to support the life-saving work of SSPs in preventing future overdose deaths and outbreaks of HIV and HCV.

This article summarizes COVID-19 harm reduction approaches taken by a family medicine/OBGYN residency program serving rural, western North Carolina for patients with an opioid use disorder. To meet patient needs, low acuity patients were offered telehealth options and digital prescriptions for buprenorphine/naloxone. For higher acuity patients, in=person visits were maintained and the risk/benefits were weighed on a continuous basis.

This resource makes recommendations related to establishing crisis stabilization systems for persons living with mental illness. This article describes how pandemic-related changes and funding increases can be leveraged to strengthen statewide crisis stabilization systems for individuals living with mental illness and substance use disorder, including recommendations for specific stakeholders to engage and action steps. The practice strategy this article is focused on is policy and organizational change to improve public health infrastructure.

This resources summarizes the impact of the COVID-19 pandemic on substance use and the experiences of people who used drugs during the COVID-19 pandemic. Highlights include: the pandemic increased the risk of overdose for people who use drugs, and in response people who use drugs reported using more harm reduction strategies. The pandemic also motivated change in wanting to quit drug use for study participants, but also highlighted the social determinants of health as barriers to sustainable recovery.

This article describes the impact of COVID-19-specific adaptations at two sites delivering a federally funded substance use treatment program for people living with or at-risk of HIV in Massachusetts. The success of the adaptations varied based on the site. For example, the transition to telemedicine was successful at the STI clinic, but not the community-based organization. However, the article does identify some adaptations that were successful in each setting, and the authors report process outcomes for these adaptations. The practice strategy this article is focused on is continuity of care for people with substance use disorder who are living with or at-risk of HIV during the COVID-19 pandemic.

This article describes the implementation of a medical student-run, free virtual clinic providing medication assisted treatment (MAT) for opioid use disorder (OUD) in Miami, Florida during the COVID-19 pandemic. Eligibility criteria for accessing services through the clinic included Florida residency and an income below 200% of the federal poverty level. The article describes how the students promoted the clinic, the process for providing MAT virtually (under supervision of an attending physician), patient characteristics, and reports process evaluation data for the clinic. The practice strategy this article is focused on is access to MAT for people with OUD during the COVID-19 pandemic.